BRIEF-CTI Biopharma pockets $15.7 mln from direct share offer

Sept 30 (Reuters) - CTI Biopharma says: * Has closed sale of 10 million shares to institutional investors in a registered direct offering * Gross proceeds from the offering around $15.7 million * Group plans to use net proceeds to support development of lead product candidate Pacritinib Source text for Eikon: (Reporting by Milan newsroom)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.